THE European Medicines
Agency’s Pharmacovigilance Risk
Assessment Committee (PRAC) has
commenced a safety review of
codeine-containing medicines
when used for post-operative pain
relief in children.
The review follows recent
concerns over an increased risk of
morphine toxicity when codeine is
given to children after surgery.
It was prompted, in particular, by
a small number of cases where a
rare but fatal or life-threatening
respiratory depression in ultrarapid
metabolising children who
were given codeine after surgical
removal of the tonsils or adenoids
in the treatment of obstructive
sleep apnoea.
As such the EMA will evaluate the
impact of the new information on
the benefit-risk balance of these
medicines when used for postoperative
pain relief in children.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Oct 12
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.